Insiders · NBRV

Robert Crotty

Officer at Nabriva Therapeutics plc (NBRV)

Robert Crotty has filed 13 insider reports with the SEC since February 2021, as officer at Nabriva Therapeutics plc (NBRV). The latest filing, on September 2, 2021, reports shares withheld for taxes or exercise price at Nabriva Therapeutics plc (NBRV).

Filings
13
Companies
1
Bought on market
None
Sold on market
None

Companies where Robert Crotty is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Nabriva Therapeutics plc logo
NBRV
Nabriva Therapeutics plc
Officer41,194Sep 2, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Robert Crotty with

Questions about Robert Crotty

What is Robert Crotty's role at Nabriva Therapeutics plc?
Robert Crotty reports to the SEC as officer at Nabriva Therapeutics plc (NBRV), according to the latest filing on September 2, 2021.
How many shares does Robert Crotty own?
After the latest filing that states it, Robert Crotty directly owned 41,194 shares of Nabriva Therapeutics plc (NBRV). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Robert Crotty bought or sold stock recently?
No open-market purchases or sales by Robert Crotty are on file. The filings report shares withheld for taxes or exercise price and grant or award.
How do I get alerts when Robert Crotty files?
Follow Robert Crotty on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Robert Crotty (SEC CIK 0001600253). Totals count each trade once, skipping amendments whose original is on file, from Feb 3, 2021 on. View on SEC EDGAR · Get this as JSON